StockData
Alaunos Therapeutics, Inc. logo

Alaunos Therapeutics, Inc. (TCRT) stock

TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.72+0.06 (+3.61%)

Close on Nov 18, 2026Market cap $4.37MP/E –Yield –

Alaunos Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Alaunos Therapeutics's market cap was $4.00M on Nov 11, 2026, against $7.37M a year earlier. Over the last 5 years it ranged from $2.21M to $531.76M, with a median of $16.84M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.00M-43.8%
2025Dec 31, 2025$7.12M+133.6%
2024Dec 31, 2024$3.05M-81.9%
2023Dec 29, 2023$16.84M-88.0%
2022Dec 30, 2022$140.32M-40.4%
2021Dec 31, 2021$235.59M-56.3%
2020Dec 31, 2020$539.67M-36.8%
2019Dec 31, 2019$854.42M+220.9%
2018Dec 31, 2018$266.24M-54.7%
2017Dec 29, 2017$587.70M-16.6%
2016Dec 30, 2016$704.73M-35.2%
2015Dec 31, 2015$1.09B+108.9%
2014Dec 31, 2014$520.61M+43.3%
2013Dec 31, 2013$363.18M+9.6%
2012Dec 31, 2012$331.22M+9.7%
2011Dec 30, 2011$301.87M+33.4%
2010Dec 31, 2010$226.28M–

More Alaunos Therapeutics figures

See a number that looks wrong?